WiCON | Pharma China (Web Edition)

ONLINE ENQUIRY

WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com

WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com

China Releases Updated NRDL and First Commercial Insurance Innovative Drug Lis... China announced on December 7 the release of an updated National Reimbursement Drug List (NRDL) and the country's first Commercial Insurance Innovative Drug List, marking...
(12/8/2025)

China's 2025 Foreign Investment Catalogue Unlo... (1/13/2026)

China's Biopharma Sector Sets New Record for I... (1/12/2026)

China's Innovative Drug Licensing Deals Reach ... (1/12/2026)

Asia Emerges as the New Epicenter of Global Bi... (1/8/2026)

Chinese Drug Makers Hit Record US$136B in Glob... (1/8/2026)

China Biopharma Approvals Surge in December as... (1/6/2026)

China Vital to Insilico's Plan to Build Biotec... (1/4/2026)

China's Beautiful Biotech Chaos vs West's Eleg... (12/30/2025)

China Leads Globally in mRNA-Based Therapeutic... (12/27/2025)

China Biotech Raises $362 Million in 18 Financ... (12/27/2025)

NSCEB: US Faces Urgent Challenge to Stay Ahead... (12/23/2025)

China Biopharma Licensing Slows in Value as Ov... (12/22/2025)

Anticancer Bioscience Secures Angel Fund... (1/12/2026) Eli Lilly Submits Orforglipron NDA in Ch... (1/12/2026) AbbVie Secures Global Rights to RemeGen... (1/12/2026) SciNeuro and Novartis Forge $1.5B Collab... (1/12/2026) Zonsen PepLib Signs $50M Licensing Deal ... (1/12/2026) Oricell Raises $70M to Fast‑Track Globa... (1/12/2026) Zenitar Raises ~CNY 600M in Major Series... (1/12/2026) Recordati Folds Operations in China (1/12/2026) Henlius Reports Promising Phase 2 Result... (1/12/2026) AirNexis Launches with $200M to Advance ... (1/9/2026) Recent Executive Moves (1/9/2026) China Rolls Out Smart Medical Insurance ... (1/9/2026) China Expands Cross-Province Use of Empl... (1/9/2026) NHSA Seeks Comments on Draft Rules for E... (1/9/2026) China Issues New Procedures for Post-App... (1/9/2026) Hengrui Secures China Approval for Retli... (1/9/2026) MediLink and Roche Expand Partnership wi... (1/9/2026) BMS/Biokin's ADC Hits Phase III Mileston... (1/8/2026)

China's Pet Obesity Sparks Biotech Race for Weight-Loss... China's Human Vaccine Market Set for Steady Long-Term E... China's Pharmaceutical Market Enters a New Consumer-Dri... China's Aging Population to Drive Trillion-Dollar Healt... China's Innovative Drug Market Shows Diverging Trends B...

Recordati Folds Operations in China Zenitar Raises ~CNY 600M in Major Series C Financing Oricell Raises $70M to Fast‑Track Global CAR‑T Progra... Zonsen PepLib Signs $50M Licensing Deal with Novartis f... SciNeuro and Novartis Forge $1.5B Collaboration on Next...

China Issues New Procedures for Post-Approval Filing Ch... NHSA Seeks Comments on Draft Rules for Early Communicat... NMPA Moves to Accelerate Approval of Overseas-Approved ... NMPA Clarifies Application of ICH Q12 to Strengthen Pha... China to Implement ICH E6(R3) Guideline for Drug Clinic...

China Expands Cross-Province Use of Employee BMI Funds ... China Rolls Out Smart Medical Insurance Payments to Imp... China Convenes National Health Work Conference to Outli... China's National Health Literacy Level Reaches 33.69% i... NHSA Seeks Public Input on Draft Guidelines for Real-Wo...

China's Supreme Court Upholds Semaglutide Patent, Stren... BeOne and AbbVie Resolve Patent Dispute O... Several Chinese Biotech Firms Added to U.S. Entity List... Chinese Scientist Arrested in Houston Over Alleged Thef... U.S. Closes Bribery Investigation into GE Healthcare's ...

Abraham Accords Partners Could Help the U.S. Reduce Pha... PhIIC Report Highlights China's API Industry Rebound as... India and China Explore Reverse-Trade Model for Pharmac... Clariant Completes Expansion of Pharma Excipients and S... Sanofi Launches €1B Insulin API Manufacturing Project ...

Henlius Reports Promising Phase 2 Results for PD-L1 ADC... Eli Lilly Submits Orforglipron NDA in China for GLP-1R ... Hengrui Secures China Approval for Retlirafusp Alfa for... Alumis Reports Positive Phase 3 Results for Envudeuciti... Curium's IND for 177Lu-PSMA-I&T Accepted for Review in ...

BioAtla and BeiGene Revise Global Deal for Novel Condit... Pfizer to Absorb Mylan, Creating Global Generic Powerho... PhRMA Calls for Trade Deals That Force Countries to Pay... IQVIA: Global Pharma to Grow Slower in the Next Five Ye... Pfizer and GSK Announce JV to Create a Global Consumer ...

Recent Executive Moves Recent Executive Moves Recent Executive Moves China Moves to Prosecute Former Traditional Medicine Re... Recent Executive Moves

China Introduces Plan for Pudong New Area's Pilot Compr... Upcoming Event: 2023 Pharma CI USA Conference & Exhibit... Upcoming Event: 15th Annual Pharma Market Research Conf... Upcoming Event: 6th International Conference on Emergin... Upcoming Event: PHARM Connect Congress

Pharma China is the most influential English media and source of business intelligence covering the Chinese pharmaceutical and biopharmaceutical sector...

WiCON has been helping international healthcare companies succeed in China and other Asian markets since 1991. We advise our clients on every stage of their China and Asian business. We worked with clients in many regions of the world...

2023 Order Form + Product Descripti... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu... WiCON Publishes the China Pharmaceu...